BaseLaunch announces that Johnson & Johnson Innovation has renewed its commitment becoming latest strategic partner in the second phase

BaseLaunch, the Basel Area-based biotech venture accelerator and incubator, today announces their renewed strategic partnership with Cilag GmbH International, one of the pharmaceutical companies of Johnson & Johnson, who becomes the latest company to join the second phase of BaseLaunch’s endeavor to fuel the next generation of biotech companies. The agreement was facilitated by Johnson & Johnson Innovation.

Read more….

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH